Advanced search
Publication Cover
Bioengineered Volume 12, 2021 - Issue 1
Submit an article Journal homepage
1,207
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

High expression of Stabilin-2 predicts poor prognosis in non-small-cell lung cancer

Juanjuan Yonga Pathology Dept. Of Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou, Guangdong Province, ChinaCorrespondence[email protected]
View further author information
,
Liyun Huangb Pathology Dept. Of Sun Yat-sen University Cancer Center of Sun Yat-Sen University, Guangzhou, Guangdong Province, ChinaCorrespondence[email protected]
View further author information
,
Gengbiao Chena Pathology Dept. Of Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou, Guangdong Province, ChinaView further author information
,
Xiaoya Luoa Pathology Dept. Of Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou, Guangdong Province, ChinaView further author information
,
Hui Chenc Obstetrics and Gynecology Dept. Of Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, ChinaView further author information
&
Lin Wanga Pathology Dept. Of Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou, Guangdong Province, ChinaORCID Iconhttps://orcid.org/0000-0002-8292-4121View further author information
ORCID Icon
Pages 3426-3433 | Received 22 Feb 2021, Accepted 09 Jun 2021, Published online: 06 Jul 2021

References

  • Pisters KM, Darling G, et al. The IASLC lung cancer staging project: “The Nodal Zone„. J Thorac Oncol. 2007;2(7):583–4.
  • Barata AT, Santos C, Cravo M, et al. Handgrip dynamometry and patient-generated subjective global assessment in patients with nonresectable lung cancer. Nutr Cancer. 2017;69(1):154–158.
  • Borghaei H, Paz-Ares L, Horn L, et al. Nivolumab versus docetaxel in advanced nonsquamous non–small-cell lung cancer. N Engl J Med. 2015;373(17):1627–1639.
  • Siegel RL, Miller KD, Jemal A et al. Cancer statistics. 2018. CA Cancer J Clin. 2018;68(1):7–30.
  • Rotow J, Bivona TG et al. Understanding and targeting resistance mechanisms in NSCLC. Nat Rev Cancer. 2017;17(11):637–658.
  • Socinski MA, Jotte RM, Cappuzzo F, et al. Atezolizumab for first-line treatment of metastatic nonsquamous NSCLC. N Engl J Med. 2018;378(24):2288–2301.
  • Wood SL, Pernemalm M, Crosbie PA, et al. Molecular histology of lung cancer: from targets to treatments. Cancer Treat Rev. 2015;41(4):361–375.
  • Wu X, Ruan L, Yang Y, et al. Analysis of gene expression changes associated with human carcinoma-associated fibroblasts in non-small cell lung carcinoma. Biol Res. 2017;50(1):6.
  • Su PL, Chen C-W, Wu Y-L, et al. First-line treatment with irreversible tyrosine kinase inhibitors associated with longer OS in EGFR mutation-positive non-small cell lung cancer. Thorac Cancer. 2021;12(3):287–296.
  • Guo Y, Song J, Wang Y, et al. Concurrent genetic alterations and other biomarkers predict treatment efficacy of EGFR-TKIs in EGFR-Mutant non-small cell lung cancer: a review. Front Oncol. 2020;10:610923.
  • Yang GJ, Li J, Xu H-Y, et al. Osimertinib for Chinese advanced non-small cell lung cancer patients harboring diverse EGFR exon 20 insertion mutations. Lung Cancer. 2021;152:39–48.
  • Falkowski M, Schledzewski K, Hansen B, et al. Expression of stabilin-2, a novel fasciclin-like hyaluronan receptor protein, in murine sinusoidal endothelia, avascular tissues, and at solid/liquid interfaces. Histochem Cell Biol. 2003;120(5):361–369.
  • Politz O, Gratchev A, McCOURT PAG, et al. Stabilin-1 and −2 constitute a novel family of fasciclin-like hyaluronan receptor homologues. Biochem J. 2002;362(1):155–164.
  • Connolly MK, Bedrosian AS, Malhotra A, et al. In hepatic fibrosis, liver sinusoidal endothelial cells acquire enhanced immunogenicity. J Immunol. 2010;185(4):2200–2208.
  • Hirose Y, Saijou E, Sugano Y, et al. Inhibition of Stabilin-2 elevates circulating hyaluronic acid levels and prevents tumor metastasis. Proc Natl Acad Sci U S A. 2012;109(11):4263–4268.
  • Neuhaus J, Schiffer E, von Wilcke P, et al. Seminal plasma as a source of prostate cancer peptide biomarker candidates for detection of indolent and advanced disease. PLoS One. 2013;8(6):e67514.
  • Han MW, Lee JC, Park S-Y, et al. Homotypic interaction of Stabilin-2 plays a critical role in lymph node metastasis of tongue cancer. Anticancer Res. 2016;36(12):6611–6618.
  • Géraud C, Mogler C, Runge A, et al. Endothelial transdifferentiation in hepatocellular carcinoma: loss of Stabilin-2 expression in peri-tumourous liver correlates with increased survival. Liver Int. 2013;33(9):1428–1440.
  • Rost MS, Sumanas S, et al. Hyaluronic acid receptor Stabilin-2 regulates Erk phosphorylation and arterial - venous differentiation in Zebrafish. PLoS One. 2014;9(2):e88614.
  • Weigel PH. Systemic Glycosaminoglycan Clearance by HARE/Stabilin-2 Activates Intracellular Signaling. Cells. 2020;9(11):2366.
  • Harris EN, Baker E, et al. Role of the Hyaluronan receptor, Stabilin-2/HARE, in health and disease. Int J Mol Sci. 2020;21(10):3504
  • Kyosseva SV, Harris EN, et al. The Hyaluronan receptor for endocytosis mediates hyaluronan-dependent signal transduction via extracellular signal-regulated kinases. J Biol Chem. 2008;283(22):15047–15055.
  • Pezzuto A, D’Ascanio M, Ricci A, et al. Expression and role of p16 and GLUT1 in malignant diseases and lung cancer: a review. Thorac Cancer. 2020;11(11):3060–3070.
  • Pezzuto A, Cappuzzo F, Arcangelo MD, et al. Prognostic value of p16 protein in patients with surgically treated non-small cell lung cancer; relationship with Ki-67 and PD-L1. Anticancer Res. 2020;40(2):983–990.
  • Reimers N, Kasper HU, Weissenborn SJ, et al. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer. 2007;120(8):1731–1738.
  • Minami K, Saito Y, Imamura H, et al. Prognostic significance of p53, Ki-67, VEGF and Glut-1 in resected stage I adenocarcinoma of the lung. Lung Cancer. 2002;38(1):51–57.
  • Sasaki H, Shitara M, Yokota K, et al. Overexpression of GLUT1 correlates with Kras mutations in lung carcinomas. Mol Med Rep. 2012;5(3):599–602.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.